The government of Castilla-La Mancha will invest 30 million euros in the year 2023 in vaccines. This was explained by the Minister of Health, Jesús Fernández Sanz, who explained that when the executive of Emiliano García-Page arrived in 2015, the budget reached 5.8 million, which represents a clear commitment from the current regional government with the prevention of protection of the population against the disease.
In this way, the health policy manager of Castilla-La Mancha highlighted “the increase between what we find in 2015 compared to the amount destined for 2023 will be more than 500 percent”.
Among the novelties that 2023 brings to the vaccination calendar, the meningococcus B vaccine and the incorporation of the human papillomavirus vaccine in boys stand out.
Free vaccine against meningococcus B
Meningococcal vaccine B will be administered from two months of age against invasive meningococcal disease.
“The decision to make it free is taken because we are sensitive to a request from scientific societies and the cost that this entails will help ease the household economy while protecting children’s health,” he stressed.
Therefore, in order to protect the most vulnerable population (under two years of age) against this disease, it is proposed to incorporate vaccination against meningococcal serogroup B disease into the infant immunization schedule with two doses at two and four months of age. , plus a memory in the second year of life.
Incorporation of human papillomavirus vaccine in boys
Human papilloma virus (HPV) genital infection is the most common sexually transmitted infection in the world.
Persistent HPV infection is a necessary, but not sufficient, cause of cervical cancer, but its causal relationship (although to a variable extent) with other cancers has also been established.
Worldwide, there is a trend towards increasing incidences of HPV-related cervical cancer, squamous cell carcinoma of the anus, and oral cavity and laryngeal cancers.
In Castilla-La Mancha, systematic HPV vaccination began in 2008 in adolescent girls, first at age 14 and subsequently vaccinated at age 12.
In recent years, many neighboring countries have introduced HPV vaccination in men, moving towards a universal vaccination strategy.
The proposed measure is to include vaccination of adolescent males in the systematic HPV vaccination schedule. Therefore, the vaccination schedule will be two doses for 12-year-old boys and girls.
Also noteworthy is the inclusion of people over the age of 50 for vaccination against shingles.
